Comparative angioprotective effects of magnesium compounds

Journal of Trace Elements in Medicine and Biology

Volumn 29, Issue , 2015, Pages 227-234

  Kharitonova, Maria ^a,c   Iezhitsa, Igor ^a,b   Zheltova, Anastasia ^a   Ozerov, Alexander ^a   Spasov, Alexander ^a   Skalny, Anatoly ^d,e  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d Russian Society of Trace Elements in Medicine   (Russian Federation)

^e Trace Elements Institute for UNESCO   (France)

Author keywords

CRP; Endothelial dysfunction; Endothelin 1; ENOS; IL 6; Inflammation; Magnesium chloride; Magnesium deficiency; Magnesium l aspartate; Magnesium N acetyltaurate; Magnesium oxybutyrate; Magnesium sulphate; TNF ; VCAM 1

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INTERLEUKIN 6; MAGNESIUM ACETYLTAURATE; MAGNESIUM ASPARTATE; MAGNESIUM CHLORIDE; MAGNESIUM DERIVATIVE; MAGNESIUM OXYBUTYRATE; MAGNESIUM SULFATE; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; BIOLOGICAL MARKER; MAGNESIUM; PROTECTIVE AGENT;

ADULT; ANGIOPROTECTIVE EFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT VASODILATATION; ENZYME BLOOD LEVEL; INFLAMMATION; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PROTEIN CONTENT; RAT; SUPPLEMENTATION; VASODILATATION; ANIMAL; BLOOD; COMPARATIVE STUDY; DRUG EFFECTS; ERYTHROCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; INFLAMMATION MEDIATORS; MAGNESIUM; MAGNESIUM COMPOUNDS; MAGNESIUM DEFICIENCY; MALE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; VASODILATION;

EID: 84919657372     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.06.026     Document Type: Article

References (45)

1. Otsuka F., Fuster V., Narula J., Virmani R. Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. Mt Sinai J Med 2012, 79(6):641-653.
2. Corti R., Fuster V., Badimon J.J. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 2003, 41(4 Suppl. S):7S-14S.
3. Kupetsky-Rincon E.A., Uitto J. Magnesium novel applications in cardiovascular disease - a review of the literature. Ann Nutr Metab 2012, 61(2):102-1.
4. Limaye C.S., Londhey V.A., Nadkart M.Y., Borges N.E. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India 2011, 59:19-22.
5. Spasov A.A., Iezhitsa I.N., Kharitonova M.V., Gurova N.A. Arrhythmogenic threshold of the myocardium under conditions of magnesium deficiency. Bull Exp Biol Med 2008, 146(1):63-65.
6. Maier J.A.M., Malpuech-Brugere C., Zimowska W., Rayssiguier Y., Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004, 1689(1):13-21.
7. Paravicini T.M., Yogi A., Mazur A., Touyz R.M. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009, 53:423-429.
8. Ferrè S., Mazur A., Maier J.A. Low-magnesium induces senescent features in cultured human endothelial cells. Magnes Res 2007, 20(1):66-71.
9. Song Y., Li T.Y., van Dam R.M., Manson J.E., Hu F.B. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007, 85(4):1068-1074.
10. 2+ supplementation restores impaired vasoactive responses in isolated rat aorta induced by chronic ethanol consumption. Eur J Pharmacol 2002, 442(3):241-250.
11. Barbagallo M., Dominguez L.J., Galioto A., Pineo A., Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010, 23(3):131-137.
12. Heidarianpour A., Sadeghian E., Gorzi A., Nazem F. The influence of oral magnesium sulfate on skin microvasculature blood flow in diabetic rats. Biol Trace Elem Res 2011, 143(1):344-350.
13. Pokan R., Hofmann P., von Duvillard S.P., Smekal G., Wonisch M., Lettner K., et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med 2006, 40(September (9)):773-778.
14. Spasov A.A., Petrov V.I., Iezhitsa I.N., Kravchenko M.S., Kharitonova M.V., Ozerov A.A. Comparative study of magnesium salts bioavailability in rats fed a magnesium-deficient diet. Vestn Ross Akad Med Nauk 2010, 2:29-37.
15. Iezhitsa I.N., Spasov A.A., Kravchenko M.S., Kharitonova M.V., Ozerov A.A., Pavlova I.Yu. Comparative study of magnesium salts' bioavailability in rats fed with magnesium-deficient diet. J Jpn Soc Magnes Res 2006, 25(2):99. [153].
16. Iezhitsa I.N., Spasov A.A., Kharitonova M.V., Kravchenko M.S. Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and l-5-hydroxytryptophan. Nutr Neurosci 2011, 14(1):10-24.
17. Zeller W., Weber H., Panoussis B., Bürge T., Bergmann R. Refinement of blood sampling from the sublingual vein of rats. Lab Anim 1998, 32(October (4)):369-376.
18. Pokrovskii M.V., Kochkarov V.I., Pokrovskaya T.G. Methodical approaches for quantative estimation of endothelial dysfunction development under conditions of l-NAME induced experimental deficiency of NO. Kubanskiĭ Nauchno-Meditsinskiĭ Vestnik 2006, 10:72-77.
19. Shah N.C., Liu J.P., Iqbal J., Hussain M., Jiang X.C., Li Z., et al. Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. Int J Clin Exp Med 2011, 4(2):103-118.
20. Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106(September (12)):1439-1441.
21. Govers R., Rabelink T.J. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001, 280(February (2)):F193-F206.
22. Chauhan S.D., Seggara G., Vo P.A., Macallister R.J., Hobbs A.J., Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 2003, 17(6):773-775.
23. Buga G.M., Griscavage J.M., Rogers N.E., Ignarro L. Negative feedback regulation of endothelial cell function by nitric oxide. J Circ Res 1993, 73(5):808-812.
24. Coleman J.W. Nitric oxide in immunity and inflammation. Int Immunopharmacol 2001, 1(8):1397-1406.
25. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107(7):2943-2951.
26. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001, 88:756-762.
27. Wallerath T., Gath I., Aulitzky W.E., Pollock J.S., Kleinert H., Förstermann U., et al. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997, 77:163-167.
28. Asahara T., Murohara T., Sullivan A., Silver M., van der Z.R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
29. Laskowska M., Laskowska K., Terbosh M., Oleszczuk J. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit 2013, 19(June):430-437. 10.12659/MSM. 883932.
30. Alqasim A. Lower level of eNOS and C-type natriuretic peptide in patients with isolated systolic hypertension. Pak J Physiol 2012, 8(1):7-11.
31. Taşolar H., Eyyüpkoca F., Aktürk E., Karakuş Y., Cansel M., Yağmur J., et al. Endothelial nitric oxide synthase levels and their response to exercise in patients with slow coronary flow. Cardiovasc J Afr 2013, 24(October-November (9/10)):355-359. 10.5830/CVJA-2013-072.
32. Li L., Huang Z., Xiao H., Chen X., Zeng J. Effect of PBNA on the NO content and NOS activity in ischemia/reperfusion injury in the rat retina. Adv Exp Med Biol 2010, 664:501-507.
33. Leroyer A.S., Ebrahimian T.G., Cochain C., Récalde A., Blanc-Brude O., Mees B., et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009, 119(June (21)):2808-2817.
34. Boehm F., Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007, 76:8-18.
35. 2+ signal elicits nitric oxide production in endothelial cells. J Biol Chem 2012, 287(November (49)):41023-41031. [Epub ahead of print]. 10.1074/jbc.M112.418533.
36. Ferrè S., Baldoli E., Leidi M., Maier J.A. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 2010, 1802(11):952-958.
37. Fitzgerald D.C., Meade K.G., McEvoy A.N., Lillis L., Murphy E.P., MacHugh D.E., et al. Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. Vet Immunol Immunopathol 2007, 116(1/2):59-68.
38. Kushner I., Jiang S.L., Zhang D., Lozanski G., Samols D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1?. Ann NY Acad Sci 1995, 762:102-107.
39. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Saito T., et al. C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis 2006, 185(1):39-46.
40. Lirk P., Hoffmann G., Rieder J. Inducible nitric oxide synthase-time for reappraisal. Curr Drug Targets Inflamm Allergy 2002, 1(March (1)):89-108.
41. Pellegrino D., Parisella M.L. Nitrite as a physiological source of nitric oxide and a signalling molecule in the regulation of the cardiovascular system in both mammalian and non-mammalian vertebrates. Recent Pat Cardiovasc Drug Discov 2010, 5(June (2)):91-96.
42. van Faassen E.E., Bahrami S., Feelisch M., Hogg N., Kelm M., Kim-Shapiro D.B., et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009, 29(September (5)):683-741.
43. Durlach J., Guiet-Bara A., Pagès N., Bac P., Bara M. Magnesium chloride or magnesium sulfate: a genuine question. Magnes Res 2005, 18(September (3)):187-192.
44. Mittendorf R., Pryde P.G., Elin R.J., Gianopoulos J.G., Lee K.S. Relationship between hypermagnesaemia in preterm labour: adverse health outcomes in babies. Magnes Res 2002, 15:253-261.
45. Nishio A., Gebrewold A., Altura B.T., Altura B.M. Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: an in situ study on microcirculation. J Pharmacol Exp Ther 1988, 246(September (3)):859-865.